LAXILOSE Drug Patent Profile
✉ Email this page to a colleague
When do Laxilose patents expire, and what generic alternatives are available?
Laxilose is a drug marketed by Nostrum Labs and is included in one NDA.
The generic ingredient in LAXILOSE is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Laxilose
A generic version of LAXILOSE was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LAXILOSE?
- What are the global sales for LAXILOSE?
- What is Average Wholesale Price for LAXILOSE?
Summary for LAXILOSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,588 |
| DailyMed Link: | LAXILOSE at DailyMed |
Recent Clinical Trials for LAXILOSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tampa General Hospital | Phase 4 |
US Patents and Regulatory Information for LAXILOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs | LAXILOSE | lactulose | SOLUTION;ORAL | 073686-001 | May 28, 1993 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
